Squarepharma: Square Pharmaceuticals PLC. Reports Earnings Results for the Second Quarter and Six Months Ended December 30, 2024

Square Pharmaceuticals PLC. reported earnings results for the second quarter and six months ended December 30, 2024. For the second quarter, the company reported sales was BDT 19,970.89 million compared to BDT 17,741.27 million a year ago. Net income was BDT 6,602.93 million compared to BDT 5,244.98 million a year ago. Basic earnings per share from continuing operations was BDT 7.45 compared to BDT 5.92 a year ago. Diluted earnings per share from continuing operations was BDT 7.45 compared to BDT 5.92 a year ago. For the six months, sales was BDT 37,717.78 million compared to BDT 35,552.5 million a year ago. Net income was BDT 12,694.85 million compared to BDT 11,245.36 million a year ago. Basic earnings per share from continuing operations was BDT 14.32 compared to BDT 12.69 a year ago. Diluted earnings per share from continuing operations was BDT 14.32 compared to BDT 12.69 a year ago.